DrugDashboards

We read 259,175 drug records this morning. The US drug supply, on the record.

Drug prices, shortages, recalls, and substitutability for every NDC on the market — refreshed daily, free, straight from the source files.

Sep 2, 2026 on the US drug market8,438 manufacturer exitsevery change →
Public programs
Prices
Supply, safety, and competition

Also here: how every number is computed · the change feed as RSS · search all 255k productsand every drug page links its manufacturer and plant profiles.

Drug News

articles, links & podcasts

Medicaid spend by state

Full detail →

Where Medicaid's outpatient drug dollars go. Expand a state for its top drugs.

ⓘ How this was built
Data sources
  • CMS State Drug Utilization Data (SDUD)
Method

Sums of CMS-reported Medicaid outpatient reimbursement per state for the latest complete year (pre-rebate). Aggregation only.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

Drug market changes — latest detected

The most recent changes from the daily diff, newest first — they can span more than one day. Shortage rows are one company's version of a drug, not the whole drug; the line beneath shows how many companies market it overall.

ⓘ How this was built
Data sources
  • FDA drug shortages, NDC Directory, drug enforcement (openFDA)
  • NADAC prices (data.medicaid.gov)
Method

A daily diff engine compares today's federal files against yesterday's; each row is one detected change (new/resolved shortage, price move, recall, market entry/exit).

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Mfr exited
    Farmak, a,s · zolpidem tartrate
  • NausiaSep 2, 2026
    Mfr exited
    Deseret Biologicals, Inc. · zingiber officinale, ipecacuanha, iris versicolor, lac defloratum, lacticum acidum, cyclamen europaeum, petroleum, tabacum, arsenicum album, bryonia (alba), cadmium sulphuratum, cocculus indicus, colchicum autumnale, conium maculatum, ferrum metallicum, nux vomica, pulsatilla (pratensis), sepia, theridion, euphorbia corollata
  • D14Sep 2, 2026
    Mfr exited
    DNA Labs, Inc. · zincum valerianicum, ignatia amara, chamomilla vulgaris, coffea cruda, kali bromatum, eschscholtzia californica, humulus lupulus, passiflora incarnata, valeriana officinalis, avena sativa
  • N-17Sep 2, 2026
    Mfr exited
    DNA Labs, Inc. · zinc, selenium, bos taurus thymus, sus scrofa spleen, bos taurus lymph, bos taurus adrenal gland, arginine, cystine, echinacea angustifolia, thiamine, pyridoxine hydrochloride, and ascorbic acid
  • Leg Pain ReliefSep 2, 2026
    Mfr exited
    Laboratoires Boiron · zinc, copper, hypericum perforatum
  • Guangzhou Saweilan Import & Export Trading Co., Ltd · zinc undecylenate, undecylenic acid
  • Mfr exited
    Renu Laboratories, Llc · zinc spf
  • Guangdong Aimu Biological Technology Co., Ltd · zinc oxide,titanium dioxide
  • Mfr exited
    Guangdong Aimu Biological Technology Co., Ltd · zinc oxide,phenylbenzimidazole sulfonic acid
  • Guangzhou Senmai Biotechnology Co.,Ltd. · zinc oxide,niacinamide,colloidal sulfur,azelaic acid,salicylic acid.
All changes, filterable →

U.S. drug spend, by payer

Who pays for the ~$467B Americans spend on retail prescriptions each year.

ⓘ How this was built
Data sources
  • CMS National Health Expenditure data
  • IQVIA industry estimates (2024)
Method

Static published estimates, shown for orientation; Medicaid is net of rebates. Not computed from our pipeline.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

Private insurance$195B · 42%Medicare$150B · 32%Out-of-pocket$65B · 14%Medicaid$47B · 10%Other public$10B · 2%Medicaid net of rebates (gross ≈ $100B+). Est: CMS NHE, IQVIA, 2024.

Most fragile drugs

Highest supply-fragility scores today — thin manufacturer bases, active shortages, recent recalls.